Little t,
I agree with your summary, I also think Acadia will take on the ROW.
They know Trof better than anyone and have spent over 100 million on the trial so far. Of course the BOD will get the best deal for SHs, so I'm expecting ACADIA to bid aggressively for ROW.
First of all, trofinetide needs to be approved by the FDA on. Or before 12th March, this year.only 4 weeks to go!
Share Price, page-3662
-
- There are more pages in this discussion • 7,266 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.48 |
Change
-0.300(1.44%) |
Mkt cap ! $2.635B | |||
| Open | High | Low | Value | Volume |
| $20.50 | $20.74 | $20.01 | $3.006M | 146.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 144 | $20.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.48 | 329 | 19 |
View Market Depth
| Last trade - 14.22pm 19/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |